Evotec SE (EVO) FCF Margin (2009 - 2025)
Evotec SE (EVO) reported FCF Margin of 32256.63% for Q4 2025, up 1263228.0% on a YoY basis from N/an in Q4 2024, and down 111550.8% sequentially from 28.89% in Q3 2025.
Evotec SE (EVO) FCF Margin (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 8 years of FCF Margin data on file, last reported at 32256.63% in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin rose 1263228.0% year-over-year to 32256.63%; the trailing twelve-month figure through Dec 2025 stood at 10274.35% (down 197107.0% YoY), and the FY2025 full-year result was 10.37%, up 1245268725.0% from the prior year.
- FCF Margin eased to 32256.63% in Q4 2025, from 28.89% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 4772.81% in Q4 2022 to a low of 44888.91% in Q4 2024.
- A 5-year average of 6731.63% and a median of 0.03% in 2021 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin plunged 3529246 bps in 2023 and surged 1263228 bps in 2025, its largest moves.
- Tracing EVO's FCF Margin over 5 years: stood at 1785.37% in 2021, then soared by 167 bps to 4772.81% in 2022, then slumped by 739 bps to 30519.65% in 2023, then sank by 47 bps to 44888.91% in 2024, then advanced by 28 bps to 32256.63% in 2025.
- Business Quant data shows EVO's FCF Margin at 32256.63% in Q4 2025, 28.89% in Q3 2025, and 44888.91% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32,256.63% |
| Sep 30, 2025 | -28.89% |
| Dec 31, 2024 | -44,888.91% |
| Sep 30, 2024 | 37.52% |
| Dec 31, 2023 | -30,519.65% |
| Sep 30, 2023 | 34.64% |
| Jun 30, 2023 | 66.00% |
| Dec 31, 2022 | 4,772.81% |
| Sep 30, 2022 | -139.49% |
| Jun 30, 2022 | 125.11% |
| Mar 31, 2022 | 64.70% |
| Dec 31, 2021 | 1,785.37% |
| Sep 30, 2021 | -4.27% |
| Jun 30, 2021 | -22.80% |
| Mar 31, 2021 | 0.03% |
| Dec 31, 2019 | 2.44% |
| Sep 30, 2010 | 27.36% |
| Jun 30, 2010 | -25.56% |
| Mar 31, 2010 | 0.00% |
| Dec 31, 2009 | -188,019,588.61% |